Arkolith/Insider Trading/AXNX/Form 4

Noblett Karen

Chief Medical OfficerAxonics, Inc. (AXNX) · full profile →Form 4 · filed Feb 2, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$765K
Net Open-Market Flow
-$765K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2024Sell(S)11K$67.74$765K34K
Jan 31, 2024Option exercise(M)28K—$046K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2024Option exercise(M)15K—$00
Jan 31, 2024Option exercise(M)7K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-001013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML